BIEL (Bioelectronics) ROE % Adjusted to Book Value: 0.00% (As of . 20)


What is Bioelectronics ROE % Adjusted to Book Value?

Bioelectronics BIEL ROE % Adjusted to Book Value is 0.00% as of . 20.

Bioelectronics's ROE % for the quarter that ended in . 20 was 0.00%. Bioelectronics's PB Ratio for the quarter that ended in . 20 was N/A. Bioelectronics's ROE % Adjusted to Book Value for the quarter that ended in . 20 was N/A.

Bioelectronics ROE % Adjusted to Book Value Related Terms

Bioelectronics ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Bioelectronics's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioelectronics ROE % Adjusted to Book Value Chart

Bioelectronics Annual Data
Trend
ROE % Adjusted to Book Value

Bioelectronics Quarterly Data
ROE % Adjusted to Book Value

BIEL vs NUVPF, ADMD, RSPI: ROE % Adjusted to Book Value Comparison

For the Medical Devices subindustry, Bioelectronics's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bioelectronics ROE % Adjusted to Book Value vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bioelectronics's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Bioelectronics's ROE % Adjusted to Book Value falls into.


Bioelectronics ROE % Adjusted to Book Value Calculation

Bioelectronics's ROE % Adjusted to Book Value for the fiscal year that ended in . 20 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

Bioelectronics's ROE % Adjusted to Book Value for the quarter that ended in . 20 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of 0.00% mean?
Bioelectronics (BIEL) has a ROE % Adjusted to Book Value of 0.00% as of . 20. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Bioelectronics and its competitors.
Is Bioelectronics' ROE % Adjusted to Book Value too high?
Bioelectronics' current ROE % Adjusted to Book Value is 0.00%.
How does Bioelectronics' ROE % Adjusted to Book Value compare to NUVPF and ADMD?
Bioelectronics' ROE % Adjusted to Book Value of 0.00% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Medical Devices & Instruments company?
A good ROE % Adjusted to Book Value depends on the Medical Devices & Instruments industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Bioelectronics and its competitors. Bioelectronics's current ROE % Adjusted to Book Value is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioelectronics stock overvalued right now?
Bioelectronics (BIEL) has a current ROE % Adjusted to Book Value of 0.00%. The current ROE % Adjusted to Book Value is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Bioelectronics (BIEL), the current ROE % Adjusted to Book Value is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bioelectronics Business Description

Address 3880 Roundtree Road, Suite 1, Jefferson, MD, USA, 21755
Bioelectronics Corp is an electroceutical company. The company develops wearable, neuromodulation devices to safely mitigate neurological diseases and improve quality of life. Its product line includes Actipatch Musculoskeletal Pain Therapy, Allay menstrual pain therapy, Smart insole heel pain therapy, and Recovery RX post operative and Chronic wounds therapy. It sells its products to wholesale distributors, directly to hospitals and clinics, and to consumers. develops & commercializes electrical stimulation/neuromodulation technology. Company products include RecoveryRx, ActiPatch Musculoskeletal Pain Relief, and Others.